Alterity Therapeutics Ltd ADR (ATHE) Stock Price, Quote & News

Company Profile

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clin...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9349 4906

Website: alteritytherapeutics.com

Address:

500 Collins Street, Level 15, Melbourne, Australia

CARTE_BLANCHE_DEVEREAUX Jul. 3 at 6:55 PM

$SLS $ATHE $CING $PYPD It's been 1 year (and 2 days) since I posted this. How did you guys do this year? What do you guys have planned for the next year? Are you paying attention (and contributing) to the Discord?

2 · Reply